Literature DB >> 35013780

Most used photobiomodulation dosimetry parameters to treat oral mucositis after preconditioning for hematopoietic stem cell transplantation: systematic review and meta-analysis.

Bruna Machado da Silva1, Maria Luiza Prosdócimo2, Larissa Rodrigues Gasparini2, Betânia Machado da Silva3, Melissa Rodrigues de Araujo2, José Miguel Amenábar2.   

Abstract

Parameter reproducibility in photobiomodulation therapy (PBMT) is still scarce in literature for the management of oral mucositis (OM). This study aimed to identify the most used PBMT dosimetry parameters (DP) and their efficacy in OM management after preconditioning for hematopoietic stem cell transplantation (HSCT). This research was conducted according to the PRISMA guidelines. The search for primary studies was in PubMed/MEDLINE, Web of Science, Embase, BVS, and Cochrane Library. Gray literature was verified on BDTD-Ibict and Open Gray. A total of 1044 studies were identified. Nine met the eligibility criteria for qualitative assessment and 7 for meta-analysis. The studies involved 396 patients submitted to preconditioning for HSCT, 211 with PBMT and 185 without PBMT in the OM management. The WHO scale was the most used to assess OM degree. The most used parameters were 660-nm wavelength, 40-mw power, 0.16-J energy, 1-W/cm2 power density, 4-J/cm2 energy density, and 0.04-cm2 spot size. The meta-analysis demonstrated that PBMT decreased the severity of OM, with a protection factor 20% higher than the control group (without PBMT), and when the parameters are similar to the DP mentioned, the protection factor increases to 94%. These most used DP with similarity seem to be a therapeutic strategy for the management of OM in this population.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Hematopoietic stem cell transplantation; Oral mucositis; Photobiomodulation; Systematic review

Mesh:

Year:  2022        PMID: 35013780     DOI: 10.1007/s00520-022-06817-w

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  23 in total

1.  Amelioration of oral mucositis pain by NASA near-infrared light-emitting diodes in bone marrow transplant patients.

Authors:  Brian D Hodgson; David M Margolis; Donna E Salzman; Dan Eastwood; Sergey Tarima; Lisa D Williams; Jane E Sande; William P Vaughan; Harry T Whelan
Journal:  Support Care Cancer       Date:  2011-07-03       Impact factor: 3.603

2.  Parameter Reproducibility in Photobiomodulation.

Authors:  Jan Tunér; Peter A Jenkins
Journal:  Photomed Laser Surg       Date:  2016-03       Impact factor: 2.796

3.  Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: a randomized trial.

Authors:  Héliton Spíndola Antunes; Alexandre Mello de Azevedo; Luiz Fernando da Silva Bouzas; Carlos Alberto Esteves Adão; Claudia Tereza Pinheiro; Renato Mayhe; Lucia Helena Pinheiro; Renato Azevedo; Valkiria D'Aiuto de Matos; Pedro Carvalho Rodrigues; Isabele Avila Small; Renato Amaro Zangaro; Carlos Gil Ferreira
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

Review 4.  Oral mucositis.

Authors:  C Scully; S Sonis; P D Diz
Journal:  Oral Dis       Date:  2006-05       Impact factor: 3.511

Review 5.  Mucositis: The impact, biology and therapeutic opportunities of oral mucositis.

Authors:  Stephen T Sonis
Journal:  Oral Oncol       Date:  2009-10-13       Impact factor: 5.337

6.  Low energy Helium-Neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial.

Authors:  D Cowen; C Tardieu; M Schubert; D Peterson; M Resbeut; C Faucher; J C Franquin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-07-01       Impact factor: 7.038

Review 7.  MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.

Authors:  Rajesh V Lalla; Joanne Bowen; Andrei Barasch; Linda Elting; Joel Epstein; Dorothy M Keefe; Deborah B McGuire; Cesar Migliorati; Ourania Nicolatou-Galitis; Douglas E Peterson; Judith E Raber-Durlacher; Stephen T Sonis; Sharon Elad
Journal:  Cancer       Date:  2014-02-25       Impact factor: 6.860

8.  Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.

Authors:  Florence Legouté; René-Jean Bensadoun; Valérie Seegers; Yoann Pointreau; Delphine Caron; Philippe Lang; Alain Prévost; Laurent Martin; Ulrike Schick; Benjamin Morvant; Olivier Capitain; Gilles Calais; Eric Jadaud
Journal:  Radiat Oncol       Date:  2019-05-22       Impact factor: 3.481

9.  Effect of An Evidence-Based Nursing Intervention on the Diagnosis of Oral Mucositis in the Pediatric Stem Cell Transplant Unit.

Authors:  Seyda Avci; Hatice Yildirim Sari
Journal:  Asia Pac J Oncol Nurs       Date:  2019 Jul-Sep

10.  MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.

Authors:  Sharon Elad; Karis Kin Fong Cheng; Rajesh V Lalla; Noam Yarom; Catherine Hong; Richard M Logan; Joanne Bowen; Rachel Gibson; Deborah P Saunders; Yehuda Zadik; Anura Ariyawardana; Maria Elvira Correa; Vinisha Ranna; Paolo Bossi
Journal:  Cancer       Date:  2020-07-28       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.